Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
Year: 2017
Type: review
Source: Drug Discovery Today
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2733185934
